Berlin 2026: European Cannabis M&A Finds its Footing
European cannabis mergers and acquisitions are gaining momentum as markets mature and regulatory frameworks stabilize. This consolidation may accelerate product standardization and quality control. The evolving landscape impacts patient access to…
In-Depth Medical Cannabis Sales Market Analysis by Application and Type
This report provides a detailed medical cannabis sales segmentation analysis by application and product type. Understanding these market dynamics is essential for clinicians to anticipate product availability and pricing pressures. The medical cannabis…
The Sobering Reality of CT’s Cannabis Market (Opinion) – Hartford Business Journal
Connecticut cannabis market challenges are impacting patient access and product availability. Economic and regulatory pressures create supply disruptions for medical cannabis patients. Clinicians must prepare patients for these market dynamics to…
Eli Lilly’s Oral GLP-1 Therapy Now Sold on Amazon
Oral GLP-1 therapy is transforming weight management with Eli Lilly’s new pill available on Amazon. This direct-to-consumer approach allows patients easier access but requires careful clinical oversight. Family physicians should integrate oral GLP-1…
The Cannabist Company Bankruptcy and Industry Consolidation Effects
The 2026 cannabis industry consolidation is reshaping patient access to medical cannabis. The Cannabist Company's bankruptcy highlights challenges in multi-state cannabis operations. This affects product availability and continuity of care for patients.
Virginia Officials Post New Marijuana Regulatory And Compliance Job Openings As …
Virginia cannabis regulatory infrastructure is advancing with new compliance job openings. This development signals progress toward adult-use cannabis sales. The framework will impact patient access and product quality standards.
How 2026 CBD Enforcement Policy Changes Are Shaping Cannabis Stocks
2026 CBD enforcement policy changes are reshaping the cannabis market landscape. Reduced FDA enforcement may improve patient access but raises concerns about product quality. Clinicians must guide patients on safe CBD use amid evolving regulations.
One-in-Ten Prescriptions of Medicinal Cannabis from Single Source – The Christian Institute
Medicinal cannabis prescribing concentration is raising important clinical concerns about treatment standardization and supply chain resilience. This pattern highlights potential conflicts of interest in the market. Understanding these prescribing…
Cambria Cannabis ETF Closes Up Shop as Investor Interest Fades – The Daily Upside
The cannabis ETF closure impact is significant for medical cannabis funding and research development. Market volatility and reduced investor interest may slow innovation in cannabis therapeutics. This affects patient access to emerging standardized…
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Cannabis operator financial performance directly affects patient access and supply chain stability. Market volatility can disrupt product availability and pricing. Understanding these dynamics is crucial for medical cannabis patients and providers.